bf/NYSE:DNA_icon.jpeg

COM:GINKGOBIOWORKS

Ginkgo Bioworks

  • Stock

USD

Last Close

6.59

22/11 21:00

Market Cap

725.64M

Beta: -

Volume Today

129

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
3.05M
-
3.86M
26.70%
2.18M
43.52%
average payables
11.04M
-
9.32M
15.59%
9.89M
6.08%
average receivables
87.04M
-
116.18M
33.49%
49.81M
57.13%
book value per share
0.31
-
1.11
256.32%
1.03
6.59%
0.68
34.00%
capex per share
-0.01
-
-0.04
160.23%
-0.04
6.75%
-0.03
25.10%
-0.03
18.47%
capex to depreciation
-2.07
-
-4.17
101.88%
-1.94
53.39%
-1.18
39.47%
-0.57
51.54%
capex to operating cash flow
0.50
-
0.43
14.43%
0.22
47.69%
0.21
6.93%
0.14
33.38%
capex to revenue
-0.41
-
-0.75
83.94%
-0.18
76.12%
-0.11
39.24%
-0.16
48.29%
cash per share
0.26
-
1.14
344.52%
0.78
31.25%
0.59
25.06%
days of inventory on hand
63.97
-
9.46
85.21%
7.80
17.57%
days payables outstanding
324.83
-
23.05
92.90%
18.68
18.95%
454.87
2,335.16%
days sales outstanding
115.10
-
174.34
51.46%
63.01
63.86%
24.90
60.47%
debt to assets
0.03
-
0.01
55.84%
0.17
1,467.35%
0.13
23.57%
debt to equity
0.04
-
0.02
58.49%
0.25
1,566.21%
0.20
20.68%
dividend yield
earnings yield
-0.01
-
-0.01
5.73%
-0.16
1,827.54%
-0.74
356.72%
-0.33
55.72%
enterprise value
14.67B
-
9.77B
33.36%
1.96B
79.90%
1.99B
1.53%
enterprise value over ebitda
-136.40
-
-5.21
96.18%
-0.90
82.69%
-2.31
156.10%
ev to operating cash flow
-107.97
-
-38.51
64.34%
-7.79
79.77%
-6.75
13.35%
ev to sales
191.31
-
31.14
83.72%
4.11
86.80%
7.93
92.88%
free cash flow per share
-0.05
-
-0.13
189.54%
-0.23
75.01%
-0.18
20.54%
-0.21
15.37%
free cash flow yield
-0.00
-
-0.01
189.54%
-0.03
113.13%
-0.11
290.70%
-0.12
15.37%
graham net net
0.13
-
0.85
549.26%
0.34
59.75%
0.24
29.60%
graham number
0.77
-
5.80
650.99%
5.40
6.85%
2.92
45.94%
income quality
0.37
-
1.07
187.64%
0.14
87.11%
0.12
13.36%
0.33
176.42%
intangibles to total assets
0
-
0.01
Infinity%
0.02
171.85%
0.07
225.15%
0.08
17.51%
interest coverage
-29.57
-
-57.45
94.27%
-770.53
1,241.13%
-20.84K
2,604.53%
9.29K
144.60%
interest debt per share
0.01
-
0.02
43.09%
0.26
1,311.38%
0.14
47.68%
inventory turnover
5.71
-
38.58
576.07%
46.80
21.31%
invested capital
0.04
-
0.02
58.49%
0.25
1,566.21%
0.20
20.68%
market cap
15.03B
-
15.03B
0%
11.30B
24.81%
2.84B
74.89%
2.72B
4.26%
net current asset value
221.44M
-
1.22B
450.68%
647.03M
46.94%
433.56M
32.99%
net debt to ebitda
3.38
-
0.81
75.97%
0.40
50.76%
0.84
108.63%
net income per share
-0.08
-
-0.09
5.73%
-1.35
1,482.79%
-1.25
7.12%
-0.56
55.72%
operating cash flow per share
-0.03
-
-0.09
204.12%
-0.19
104.07%
-0.15
19.53%
-0.18
22.39%
payables turnover
1.12
-
15.84
1,309.42%
19.54
23.38%
0.80
95.89%
receivables turnover
3.17
-
2.09
33.98%
5.79
176.69%
14.66
153.00%
research and ddevelopement to revenue
1.78
-
2.08
17.27%
3.66
75.76%
2.20
39.85%
2.31
4.79%
return on tangible assets
-0.19
-
-0.91
378.82%
-0.89
1.78%
-0.58
34.54%
revenue per share
0.04
-
0.05
41.48%
0.23
347.10%
0.28
23.28%
0.16
45.02%
roe
-0.27
-
-1.22
344.20%
-1.21
0.57%
-0.81
32.92%
roic
-0.28
-
-1.18
319.39%
-0.85
28.15%
-0.56
33.70%
sales general and administrative to revenue
0.54
-
0.50
8.16%
2.75
450.26%
2.99
8.85%
1.53
48.84%
shareholders equity per share
0.31
-
1.11
256.32%
1.03
6.59%
0.68
34.00%
stock based compensation to revenue
0.01
-
0.01
56.36%
5.12
82,312.23%
4.04
21.02%
0.91
77.38%
tangible asset value
464.90M
-
1.52B
227.90%
1.57B
2.66%
965.17M
38.33%
tangible book value per share
0.31
-
1.12
258.10%
0.93
16.85%
0.60
35.58%
working capital
353.32M
-
1.59B
349.53%
1.28B
19.59%
837.89M
34.39%

All numbers in USD (except ratios and percentages)